SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

52,540.96 1,234.23
(2.41%)

Dow Jones

7,582.98 185.12
(2.50%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,779.79 105.85
(0.99%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

28.81

64565.1

EPS(TTM)

Face Value()

Div & Yield %

187.45

0.98

Back

Tanla Platforms consolidated net profit rises 20.07% in the June 2026 quarter

Jul 23,2026

Net profit of Tanla Platforms rose 20.07% to Rs 142.17 crore in the quarter ended June 2026 as against Rs 118.41 crore during the previous quarter ended June 2025. Sales rose 17.85% to Rs 1226.39 crore in the quarter ended June 2026 as against Rs 1040.66 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1226.39	1040.66	18
OPM %	16.40	15.75	-
PBDT	214.16	174.59	23
PBT	181.28	147.44	23
NP	142.17	118.41	20

81,106.65 107.25 ( 0.13%)

52,540.96 1,234.23 (2.41%)

7,582.98 185.12 (2.50%)

58,738.13 1,303.36 (2.27%)

10,779.79 105.85 (0.99%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)